Abstract
Background— Cerebrovascular disease (CVD) and ischemic brain injury secondary to cardiovascular disease are common causes of dementia and cognitive decline in the elderly. CVD also contribut READ MORE http://stroke.ahajournals.org/cgi/content/full/35/4/1010
Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
Erkinjuntti T, Román G, Gauthier S.
Helsinki University Central Hospital, Helsinki, Finland. T READ MORE http://www.ncbi.nlm.nih.gov/pubmed/15537522
This general overview of cholinesterase inhibitors discusses their use in treating vascular dementia.
The Management of Alzheimer's Disease and Related Dementias: Part 2 -- The Role of Cholinestera READ MORE http://cme.medscape.com/viewarticle/467554_1
19 September 2003. Two similar studies funded by Eisai and Pfizer companies, the developer and US-promoter of the acetylcholinesterase inhibitor drug donepezil, suggest that their drug, already widely READ MORE http://www.alzforum.org/new/detail.asp...
Patients with vascular dementia (VaD) are typically prescribed the same medicines as patients with Alzheimer's. In addition, they need medicines to help control the underlying cardiovascular problems.